Medwatch


Also found in: Wikipedia.

Medwatch

An FDA-sponsored program intended to increase the reporting of adverse effects of drugs and biologicals, and identify adverse interactions between two or more therapeutic agents during their clinical use.

MedWatch

(mĕd′wătch)
A voluntary and confidential program of the Food and Drug Administration (FDA) for monitoring the safety of drugs, biologicals, medical devices, and nutritional products such as dietary supplements, medical foods, and infant formulas. The FDA provides forms for reporting adverse events associated with any of these products. Health professionals may obtain the form by calling 1-800-332-1088. Information may be faxed to the FDA by calling 1-800-332-0178.
References in periodicals archive ?
Patients and health care professionals should report possible side effects involving the Zecuity patch to the FDA MedWatch program at www.
A review of adverse events reported to manufacturer AbbVie and to the FDA MedWatch program identified serious side effects in patients with underlying liver cirrhosis, including hepatic decompensation and liver failure, the FDA said in a statement.
Physicians and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program at http://www.
To select Wikipedia articles for evaluation, the authors chose a convenience sample of drugs for which a recent safety alert was published on the Food and Drug Administration (FDA) MedWatch website <http://www.
Health professionals and patients are encouraged to report adverse effects to FDA's MedWatch Safety Information and Adverse Event Reporting Program at www.
14 issued a MedWatch recommendation that health care providers refrain from prescribing combinations with larger acetaminophen doses.
To report adverse events related to activated drotrecogin alfa, contact MedWatch, the FDA's safety information and adverse event reporting program, online at http://www.
Adverse reactions associated with PPIs should be reported to the FDA's MedWatch program at 800-332-1088 or www.
To that end, FDA MedWatch is announcing a MedWatch mobile pilot to evaluate the effectiveness of using text messaging to send our popular MedWatch Safety Alerts, currently disseminated by standard e-mail [www.
The FDA advises healthcare professionals to report serious adverse events or product quality problems with the use of any of these products to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail, FAX, or phone.
Subscribing to FDA's MedWatch listserv notification or RSS news feeds at http://www.
Reports of medical equipment malfunctions that cause or could cause death or serious injury should be made by using FDA's MedWatch 3500A form, available at https:// www.